Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.380
+0.010 (0.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $189.87 million as of December 20, 2024. Its market cap has decreased by -13.89% in one year.
Market Cap
189.87M
Enterprise Value
61.35M
1-Year Change
-13.89%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $189.87M, a decrease of -56.38%. That is a compound annual growth rate of -20.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 189.87M | -4.50% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 191.95M |
| Amarin Corporation | 191.48M |
| Gossamer Bio | 190.55M |
| Molecular Partners AG | 190.02M |
| Fate Therapeutics | 189.06M |
| Stereotaxis | 188.10M |
| Cybin | 186.41M |
| MediWound | 185.59M |